| Peter E Diedrichsen, MD | |
|
3772 43rd Ave, Suite A, Columbus, NE 68601-1681 | |
| (402) 563-3686 | |
| (402) 564-1797 |
| Full Name | Peter E Diedrichsen |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 45 Years |
| Location | 3772 43rd Ave, Columbus, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194702597 | NPI | - | NPPES |
| 47082635813 | Medicaid | NE | |
| 01493 | Other | NE | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 14980 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Columbus Community Hospital | Columbus, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eye Physicians, P.c. | 5698863579 | 9 |
News Archive
Svelte Medical Systems today announced enrollment of the final patient in the DIRECT II (Direct Implantation of Rapamycin-Eluting stents with bioabsorbable drug Carrier Technology) clinical study. DIRECT II is a prospective, randomized study comparing the safety and efficacy of the Svelte drug-eluting coronary stent Integrated Delivery System (IDS) to the Medtronic Resolute Integrity drug-eluting stent in 159 patients at 19 investigative sites.
A newly discovered human gene mutation appears to contribute both to unusual sleep patterns and to heightened rates of seasonal depression, according to new research from UC San Francisco.
Research during the past 30 years has found many benefits of skin-to-skin contact between mothers and newborns immediately after birth, particularly with aiding breastfeeding. However, in some hospitals, skin-to-skin contact following cesarean birth is not implemented, due to practices around the surgery. A recent Quality Improvement (QI) project demonstrated that women's birth experiences were improved by implementing skin-to-skin contact after cesarean surgery.
Highlighting the recent case of an infant reportedly cured of HIV infection "after a swiftly administered course of drugs," Scientific American writes, "A number of factors make the child's case unique, ... and clinicians caution that we have not discovered a general cure for HIV yet. Still, the medical first may hint at ways to fight the AIDS-causing virus."
Several potentially preventable deficiencies, including failure to select optimal drug doses and suitable outcome measures for a study, accounted for significant delays in the approval of new drugs by the Food and Drug Administration (FDA), according to a study in the January 22/29 issue of JAMA.
› Verified 5 days ago
| Entity Name | Eye Physicians, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497732895 PECOS PAC ID: 5698863579 Enrollment ID: O20071109000251 |
News Archive
Svelte Medical Systems today announced enrollment of the final patient in the DIRECT II (Direct Implantation of Rapamycin-Eluting stents with bioabsorbable drug Carrier Technology) clinical study. DIRECT II is a prospective, randomized study comparing the safety and efficacy of the Svelte drug-eluting coronary stent Integrated Delivery System (IDS) to the Medtronic Resolute Integrity drug-eluting stent in 159 patients at 19 investigative sites.
A newly discovered human gene mutation appears to contribute both to unusual sleep patterns and to heightened rates of seasonal depression, according to new research from UC San Francisco.
Research during the past 30 years has found many benefits of skin-to-skin contact between mothers and newborns immediately after birth, particularly with aiding breastfeeding. However, in some hospitals, skin-to-skin contact following cesarean birth is not implemented, due to practices around the surgery. A recent Quality Improvement (QI) project demonstrated that women's birth experiences were improved by implementing skin-to-skin contact after cesarean surgery.
Highlighting the recent case of an infant reportedly cured of HIV infection "after a swiftly administered course of drugs," Scientific American writes, "A number of factors make the child's case unique, ... and clinicians caution that we have not discovered a general cure for HIV yet. Still, the medical first may hint at ways to fight the AIDS-causing virus."
Several potentially preventable deficiencies, including failure to select optimal drug doses and suitable outcome measures for a study, accounted for significant delays in the approval of new drugs by the Food and Drug Administration (FDA), according to a study in the January 22/29 issue of JAMA.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter E Diedrichsen, MD Po Box 1275, Columbus, NE 68602-1681 Ph: (402) 563-3686 | Peter E Diedrichsen, MD 3772 43rd Ave, Suite A, Columbus, NE 68601-1681 Ph: (402) 563-3686 |
News Archive
Svelte Medical Systems today announced enrollment of the final patient in the DIRECT II (Direct Implantation of Rapamycin-Eluting stents with bioabsorbable drug Carrier Technology) clinical study. DIRECT II is a prospective, randomized study comparing the safety and efficacy of the Svelte drug-eluting coronary stent Integrated Delivery System (IDS) to the Medtronic Resolute Integrity drug-eluting stent in 159 patients at 19 investigative sites.
A newly discovered human gene mutation appears to contribute both to unusual sleep patterns and to heightened rates of seasonal depression, according to new research from UC San Francisco.
Research during the past 30 years has found many benefits of skin-to-skin contact between mothers and newborns immediately after birth, particularly with aiding breastfeeding. However, in some hospitals, skin-to-skin contact following cesarean birth is not implemented, due to practices around the surgery. A recent Quality Improvement (QI) project demonstrated that women's birth experiences were improved by implementing skin-to-skin contact after cesarean surgery.
Highlighting the recent case of an infant reportedly cured of HIV infection "after a swiftly administered course of drugs," Scientific American writes, "A number of factors make the child's case unique, ... and clinicians caution that we have not discovered a general cure for HIV yet. Still, the medical first may hint at ways to fight the AIDS-causing virus."
Several potentially preventable deficiencies, including failure to select optimal drug doses and suitable outcome measures for a study, accounted for significant delays in the approval of new drugs by the Food and Drug Administration (FDA), according to a study in the January 22/29 issue of JAMA.
› Verified 5 days ago